Nicole Streiner

2.4k citations

16 papers · 1.4k indexed · h-index 9

Co-authors: Adam Siddiqui-Jain Sean O’Brien David M. Ryckman Denis Drygin Kenna Anderes William G. Rice Caroline B. Ho Chris Proffitt
Topics: PI3K/AKT/mTOR signaling in cancer (3 papers)Synthesis and biological activity (2 papers)Cancer Mechanisms and Therapy (2 papers)
Cited by: Molecular Biology Oncology Genetics
Journals: Journal of the American Chemical Society Journal of Clinical Oncology Blood
Partner nations: United States Australia

In The Last Decade

Nicole Streiner

16 papers receiving 1.4k citations

Peers

Countries citing papers authored by Nicole Streiner

Since Specialization

Citations

This map shows the geographic impact of Nicole Streiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Streiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Streiner more than expected).

Fields of papers citing papers by Nicole Streiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Streiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Streiner. The network helps show where Nicole Streiner may publish in the future.

Co-authorship network of co-authors of Nicole Streiner

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Streiner. A scholar is included among the top collaborators of Nicole Streiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Streiner. Nicole Streiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Characterizing Intra-Tumor and Inter-Tumor Variability of Immune Cell Infiltrates in Murine Syngeneic Tumors 2021 ·American Journal Of Pathology ·(unknown),Alan Opsahl,(unknown),Dingzhou Li,Nicole Streiner,Jinwei Wang,(unknown),(unknown),Timothy Coskran,Shawn P. O’Neil,Sripad Ram	2
2	CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy 2012 ·Molecular Cancer Therapeutics ·Adam Siddiqui-Jain,Joshua Bliesath,(unknown),Mayuko Omori,Nanni Huser,Nicole Streiner,Caroline B. Ho,Kenna Anderes,Chris Proffitt,Sean O’Brien,John K. C. Lim,Daniel D. Von Hoff,David M. Ryckman,William G. Rice,Denis Drygin	86
3	Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells 2012 ·Bioorganic & Medicinal Chemistry Letters ·Fabrice Pierre,(unknown),(unknown),Adam Siddiqui-Jain,(unknown),Nicole Streiner,Denis Drygin,Mustapha Haddach,Sean O’Brien,William G. Rice,David M. Ryckman	28
4	Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells 2012 ·Cancer Letters ·Joshua Bliesath,Nanni Huser,Mayuko Omori,(unknown),Chris Proffitt,Nicole Streiner,Caroline B. Ho,Adam Siddiqui-Jain,Sean O’Brien,John K. C. Lim,David M. Ryckman,Kenna Anderes,William G. Rice,Denis Drygin	59
5	Abstract 5270: Evaluation of Cell-able spheroid culture system for culturing patient derived primary tumor cells 2012 ·Cancer Research ·(unknown),Nicole Streiner,(unknown),Kenna Anderes,Koichi Yokota,(unknown)	1
6	Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties 2011 ·Bioorganic & Medicinal Chemistry Letters ·Fabrice Pierre,Sean O’Brien,Mustapha Haddach,Pauline Bourbon,Michael K. Schwaebe,Eric Stefan,Levan Darjania,Ryan Stansfield,Caroline B. Ho,Adam Siddiqui-Jain,Nicole Streiner,William G. Rice,Kenna Anderes,David M. Ryckman	28
7	7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity 2011 ·Bioorganic & Medicinal Chemistry Letters ·Fabrice Pierre,Eric Stefan,(unknown),(unknown),(unknown),Adam Siddiqui-Jain,(unknown),Nicole Streiner,Denis Drygin,Mustapha Haddach,Sean O’Brien,Kenna Anderes,David M. Ryckman	46
8	PP 64 Predictive assays for targeted therapeutics using image-based high content analysis of patient-derived tumor models 2011 ·European Journal of Cancer ·(unknown),Robert Tseng,Nicole Streiner,(unknown),Cyrus Mirsaidi,Thomas Broudy,Kenna Anderes	1
9	Abstract 5494: CX-4945, an inhibitor of protein kinase CK2, potentiates the antitumor activity of platinum chemotherapy in models of ovarian cancer by preventing phosphorylation of XRCC1 and MDC1 and disrupting DNA damage repair 2011 ·Cancer Research ·Adam Siddiqui-Jain,Nicole Streiner,Josh Bliesath,(unknown),Mayuko Omori,Nanni Huser,Caroline B. Ho,Sean O’Brien,Denis Drygin,Kenna Anderes	1
10	Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth 2010 ·Cancer Research ·Denis Drygin,Amy Lin,Josh Bliesath,Caroline B. Ho,Sean O’Brien,Chris Proffitt,Mayuko Omori,Mustapha Haddach,Michael K. Schwaebe,Adam Siddiqui-Jain,Nicole Streiner,Jaclyn Quin,Elaine Sanij,Megan J. Bywater,Ross D. Hannan,David M. Ryckman,Kenna Anderes,William G. Rice	462
11	CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy 2010 ·Cancer Research ·Adam Siddiqui-Jain,Denis Drygin,Nicole Streiner,Peter Chua,Fabrice Pierre,Sean O’Brien,Josh Bliesath,Mayuko Omori,Nanni Huser,Caroline B. Ho,Chris Proffitt,Michael K. Schwaebe,David M. Ryckman,William G. Rice,Kenna Anderes	421
12	CX-4945, a Selective and Orally Bioavailable Inhibitor of Protein Kinase CK2 Inhibits PI3K/Akt, JAK-STAT and NF-κB Signaling and Induces Apoptosis In Multiple Myeloma Cells 2010 ·Blood ·Caroline B. Ho,Rachel Rice,Denis Drygin,Josh Bliesath,Nicole Streiner,Adam Siddiqui-Jain,Chris Proffitt,Sean O’Brien,Kenna Anderes	3
13	Effect of CX-4945, a selective bioavailable small molecule inhibitor of protein kinase CK2, on gemcitabine antitumor activity in A2780 ovarian cancer. 2010 ·Journal of Clinical Oncology ·Kenna Anderes,Nicole Streiner,May Omori,Nanni Huser,(unknown),Adam Siddiqui-Jain,Josh Bliesath,Shane W. O’Brien,Denis Drygin,William G. Rice	3
14	Abstract C198: CX-4945, a novel small molecule inhibitor of CK2 protein kinase, reduces hyperactivated Akt signaling and synergizes with Akt inhibitors in breast cancer cells 2009 ·Molecular Cancer Therapeutics ·Denis Drygin,Josh Bliesath,Caroline B. Ho,Adam Siddiqui-Jain,Sean O’Brien,Mayuko Omori,Nanni Huser,Chris Proffitt,Nicole Streiner,William G. Rice,Kenna Anderes	1
15	Early Placental Insulin-Like Protein (INSL4 or EPIL) in Placental and Fetal Membrane Growth1 2005 ·Biology of Reproduction ·Lynnae K. Millar,Nicole Streiner,(unknown),Sandra Y. Yamamoto,Rachel Okabe,(unknown),(unknown),Erika E. Büllesbach,Christian Schwabe,Gillian D. Bryant‐Greenwood	22
16	Design and Synthesis of an Expanded Porphyrin That Has Selectivity for the c-MYC G-Quadruplex Structure 2005 ·Journal of the American Chemical Society ·Jeyaprakashnarayanan Seenisamy,Bashyam Sridevi,Vijay Gokhale,Hariprasad Vankayalapati,Daekyu Sun,Adam Siddiqui-Jain,Nicole Streiner,Kazuo Shin‐ya,(unknown),W. David Wilson,Laurence H. Hurley	271

About Nicole Streiner

Nicole Streiner is a scholar working on Oncology, Biophysics and Molecular Biology, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Synthesis and biological activity (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Oncology (312 citations) and Genetics (75 citations). Nicole Streiner has collaborated with scholars based in United States and Australia. Frequent co-authors include Adam Siddiqui-Jain, Sean O’Brien, David M. Ryckman, Denis Drygin, Kenna Anderes, William G. Rice, Caroline B. Ho, Chris Proffitt, Mayuko Omori and Michael K. Schwaebe. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact